U.S. markets open in 6 hours 18 minutes

Agilent Technologies, Inc. (A)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
146.63+0.22 (+0.15%)
At close: 4:04PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close146.41
Open146.37
Bid0.00 x 900
Ask0.00 x 1000
Day's Range145.83 - 147.64
52 Week Range84.80 - 147.68
Volume1,191,547
Avg. Volume1,484,336
Market Cap44.494B
Beta (5Y Monthly)1.01
PE Ratio (TTM)49.04
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.78 (0.53%)
Ex-Dividend DateJul 02, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-10% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Agilent Completes the InfinityLab Bio LC Portfolio
    Business Wire

    Agilent Completes the InfinityLab Bio LC Portfolio

    SANTA CLARA, Calif., Jun 22, 2021--Agilent Technologies Inc. (NYSE: A) today announced the launch of three InfinityLab Bio LC systems specifically developed to meet the needs of the biopharma industry. The release is central to the Agilent portfolio of complete Bio LC solutions, featuring instruments, columns, and supplies that seamlessly integrate with Agilent OpenLab and MassHunter software, and CrossLab services to maximize efficiency in biopharma labs.

  • Agilent Presents Thought Leader Award to Dr. Stéphane Bayen
    Business Wire

    Agilent Presents Thought Leader Award to Dr. Stéphane Bayen

    SANTA CLARA, Calif., Jun 14, 2021--Agilent Technologies Inc. (NYSE: A) today announced that Stéphane Bayen has received an Agilent Thought Leader Award. Dr. Bayen is an Associate Professor in the Department of Food Science and Agricultural Chemistry at McGill University in Montreal, Quebec, Canada.

  • Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer
    Business Wire

    Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer

    Agilent Technologies Inc. (NYSE: A) today announced a presentation by Memorial Sloan Kettering Cancer Center (MSK) at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO) to discuss the Resolution ctDx Lung, a laboratory-developed test (LDT) developed by Resolution Bioscience.